S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5551
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes ; day:8 ; month:2 ; year:2019 ; pages:1-13
Leukemia ; (8.2.2019), 1-13
- Urheber
-
Cheng, Pinyang
Eksioglu, Erika A.
Chen, Xianghong
Kandell, Wendy
Trinh, Thu Le
Cen, Ling
Qi, Jin
Sallman, David A.
Zhang, Yu
Tu, Nhan
Adams, William A.
Zhang, Chunze
Liu, Jinhong
Cleveland, John L.
List, Alan F.
Wei, Sheng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-019-0397-9
- URN
-
urn:nbn:de:101:1-2019031018071485984203
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cheng, Pinyang
- Eksioglu, Erika A.
- Chen, Xianghong
- Kandell, Wendy
- Trinh, Thu Le
- Cen, Ling
- Qi, Jin
- Sallman, David A.
- Zhang, Yu
- Tu, Nhan
- Adams, William A.
- Zhang, Chunze
- Liu, Jinhong
- Cleveland, John L.
- List, Alan F.
- Wei, Sheng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Myelodysplastic syndromes
Myelodysplastic syndromes
Kinetic Changes of Hematopoiesis During Aging, in Clonal Hematopoiesis of Indeterminate Potential, and in Myelodysplastic Syndromes
Feedback Signals in Myelodysplastic Syndromes: Increased Self-Renewal of the Malignant Clone Suppresses Normal Hematopoiesis
Soluble PD-L1 as a novel biomarker predicts poor outcomes and disease progression in de novo myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Myelodysplastic syndromes
Myelodysplastic syndromes
Kinetic Changes of Hematopoiesis During Aging, in Clonal Hematopoiesis of Indeterminate Potential, and in Myelodysplastic Syndromes
Feedback Signals in Myelodysplastic Syndromes: Increased Self-Renewal of the Malignant Clone Suppresses Normal Hematopoiesis
Soluble PD-L1 as a novel biomarker predicts poor outcomes and disease progression in de novo myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Myelodysplastic syndromes
Myelodysplastic syndromes
Kinetic Changes of Hematopoiesis During Aging, in Clonal Hematopoiesis of Indeterminate Potential, and in Myelodysplastic Syndromes
Feedback Signals in Myelodysplastic Syndromes: Increased Self-Renewal of the Malignant Clone Suppresses Normal Hematopoiesis
Soluble PD-L1 as a novel biomarker predicts poor outcomes and disease progression in de novo myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes: Where do we stand?